COMMUNIQUÉS West-GlobeNewswire

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
12/12/2025
Across multiple published studies, the test consistently identifies high-risk patients whose progression rates exceed guideline-based actionable thresholds for intensified care FRIENDSWOOD, Texas, Dec. 12, 2025 (GLOBE [...]
Nova Leap Health Corp. Grants Stock Options
12/12/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
12/12/2025
BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will [...]
Harold Health Launches New Telehealth Platform Supporting Men’s Mental and Physical Well-being
12/12/2025
New HIPAA and HL7 compliant app offers a holistic approach to men's health with on-demand providers, community support, and cutting-edge mental health and wellness therapies Miami, Florida, Dec. 12, 2025 (GLOBE NEWSWIRE [...]
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
12/12/2025
Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement in 2L/3L EGFR WT [...]
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
12/12/2025
On track to file a Clinical Trial Application (CTA) by year end 2025, with initial clinical data expected mid-2026 Important step in developing scalable and accessible ‘off-the-shelf’ cell therapy for patients with [...]
Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure
12/12/2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company” or “Axe Compute”) today announced that it has changed its name to Axe Compute Inc., with its common stock to begin trading on [...]
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
12/12/2025
This agreement expands RadioMedix’s access to essential 228 Th resources, strengthening the Company’s 212 Pb pipeline and generator platform for its long-term Targeted Alpha Therapy strategy HOUSTON, Dec. 12, 2025 ( [...]
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best [...]
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
12/12/2025
GAITHERSBURG, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) [...]
NewGen to Exercise Option to Convert Ras Al Khaimah Joint Venture into Joint Development, Projected to Boost Profits from US$67 Million to US$123 Million
12/12/2025
Strategic Move to Unlock Further Value and Accelerate Project Momentum with Planned Fundraising and Upcoming Presale Launch BANGKOK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (“NewGen” or the “Company,” [...]
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
12/12/2025
Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
12/12/2025
Final Decision from European Commission Expected in Q1 2026 SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Committee for Medicinal [...]
Additional Confirmed Response Reported as Part of Amplia Investor Presentation
12/12/2025
HIGHLIGHTS An additional confirmed partial response has been recorded in the ongoing ACCENT trial This brings the confirmed Objective Response Rate to 35% Updated data to be presented at the Life Sciences Virtual [...]
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
12/12/2025
The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy ® 7.2 mg dose, advancing its availability in the European Union (EU) In the STEP UP programme, people with obesity taking Wegovy ® 7.2 [...]
Parexel Named “Best Contract Research Organization” at 21st Annual Scrip Awards
12/12/2025
Industry leader recognized for excellence and innovation in clinical development RALEIGH, N.C., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven [...]
Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain
12/12/2025
IND filing and initiation of Phase 2 clinical trials on track for 1H 2026 SAN DIEGO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company focused on the [...]
Tenaya Therapeutics Announces Pricing of Public Offering
12/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
MedSpa Marketing Partners Unveils NORA: The AI Revolution in MedSpa Client Engagement
12/12/2025
SACRAMENTO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- MedSpa Marketing Partners launches NORA, an AI-powered voice agent, transforming client engagement and appointment bookings for medical spas 24/7. Introduction: A [...]

Pages